NIOX Group (NIOX) Share Price, News & Analysis

Company Overview

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings. Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries. NIOX is committed to enabling more precise and personalised care for patients with respiratory conditions, with a focus on quality, innovation, and scientific excellence.

Key Stats

• Today's Range: 72.60 to 77.60
• 50-Day Range: 63.60 to 73.60
• 52-Week Range: 53.40 to 80
• Volume: 2.21 million shs
• Average Volume: 1.10 million shs
• Market Capitalization: £31.21 billion
• P/E Ratio: 3,136.39
• Dividend Yield: 1.32%
• Price Target: GBX 90
• Consensus Rating: Buy

NIOX Stock Analysis - Frequently Asked Questions

How have NIOX shares performed this year?

NIOX Group's stock was trading at GBX 63 on January 1st, 2025. Since then, NIOX stock has increased by 20.6% and is now trading at GBX 76.

How were NIOX Group's earnings last quarter?

NIOX Group Plc (LON:NIOX) released its quarterly earnings results on Tuesday, April, 1st. The company reported $2.27 EPS for the quarter. NIOX Group had a net margin of 28.21% and a trailing twelve-month return on equity of 13.29%.

How do I buy shares of NIOX Group?

Shares of NIOX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of NIOX Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NIOX Group investors own include Petrofac (PFC), MICT (MICT), Chemring Group (CHG) and N Brown Group (BWNG).

Company Calendar

• Last Earnings: 4/01/2025
• Today: 8/29/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: LON:NIOX
• CIK: N/A
• Web: investors.niox.com
• Phone: 44 18 6540 5560
• Fax: N/A
• Employees: 92
• Year Founded: N/A

Price Target and Rating

• Average Price Target for NIOX Group: GBX 90
• High Price Target: GBX 90
• Low Price Target: GBX 90
• Potential Upside/Downside: +22.4%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): GBX 0.02
• Trailing P/E Ratio: 3,035.28
• Forward P/E Ratio: 63.09
• P/E Growth: N/A
• Net Income: £995.88 million
• Net Margins: 28.21%
• Pretax Margin: N/A
• Return on Equity: 13.29%
• Return on Assets: 3.95%

Debt

• Debt-to-Equity Ratio: 1.10
• Current Ratio: 6.31
• Quick Ratio: 1.94

Sales & Book Value

• Annual Sales: £3.53 billion
• Price / Sales: 8.56
• Cash Flow: GBX 6.56 per share
• Price / Cash Flow: 11.21
• Book Value: GBX 18.03 per share
• Price / Book: 4.08

Miscellaneous

• Outstanding Shares: 41,071,615,003
• Free Float: N/A
• Market Cap: £30.21 billion
• Optionable: Not Optionable
• Beta: 0.92